Drug-induced or toxic liver disease with chronic hepatitis (Q43588): Difference between revisions

@@ description / pt-br / description / pt-br @@
+É uma forma crônica de lesão hepática induzida por droga que quase sempre depende da exposição continuada ao agente e é caracterizada por hepatite de interface, necrose em ponte e fibrose.
@@ description / en / description / en @@
+This is the chronic form of drug-induced liver injury that almost always depends on continued exposure to the agent, and is characterised by interface hepatitis, bridging necrosis, and fibrosis.
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/180194892
@@ Property / Canonical URI: https://id.who.int/icd/entity/180194892 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:DB95.1
@@ Property / CURIE: CID11:DB95.1 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-DB95.1
@@ Property / Canary Token: dki-india-DB95.1 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+K71
@@ Property / Linked ICD 10: K71 / rank @@
+Normal rank

Latest revision as of 10:39, 13 August 2026

This is the chronic form of drug-induced liver injury that almost always depends on continued exposure to the agent, and is characterised by interface hepatitis, bridging necrosis, and fibrosis.

Language	Label	Description	Also known as
default for all languages	DB95.1
English	Drug-induced or toxic liver disease with chronic hepatitis	This is the chronic form of drug-induced liver injury that almost always depends on continued exposure to the agent, and is characterised by interface hepatitis, bridging necrosis, and fibrosis.